New Hanover Regional Medical Center is launching a major research study within the COVID-19 Community Research Partnership with Wake Forest Baptist Health (WFBH). This research uses symptom tracking and antibody testing as tools to determine the prevalence of COVID-19 in our communities. The study is being led locally by Dr. Patrick Maguire, NHRMC Radiation Oncology, and Dr. Charin Hanlon, director of NHRMC Internal Medicine Residency Program.
“Our hope is that data from this study will fill a critical gap in geographical mapping and projection modeling to help us picture what the future of COVID-19 will look like – not only in our region and state, but across the country,” said Dr. Maguire. “We are optimistic that the data will help guide NHRMC, WFBH, and other healthcare systems to better respond to this pandemic and prepare for the future.”
All NHRMC patients age 18 years and older are be eligible to participate in this confidential study. It consists of daily in-home symptom tracking, which will take less than two minutes daily to complete. Participants will also complete a surgery, which will cover the following:
• Your COVID-19 illness history or symptoms
• Your visits to the doctor and treatments
• Your contact with other sick people
• If you are a healthcare worker, your use of personal protective equipment
Some participants will be asked to conduct monthly in-home blood testing using a pin prick kit, which will take less than 10 minutes to complete.
No treatments are offered as part of this study. Participants are encouraged to continue following all state and federal guidelines to protect themselves and others from COVID-19.
To learn more, visit www.nhrmc.org/covid-19-study.